Application 210331
- Type
- NDA
- Sponsor
- EYEPOINT PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | YUTIQ | FLUOCINOLONE ACETONIDE | IMPLANT;INTRAVITREAL | 0.18MG | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 71879-136 | YUTIQ | fluocinolone acetonide | EyePoint Pharmaceuticals, Inc | NDA | Current |
| 71879-136 | YUTIQ | fluocinolone acetonide | EyePoint Pharmaceuticals US, Inc | NDA | Current |
| 71879-136 | YUTIQ | fluocinolone acetonide | EyePoint Pharmaceuticals, Inc | NDA | Current |
| 71879-136 | YUTIQ | fluocinolone acetonide | EyePoint Pharmaceuticals, Inc | NDA | Current |
| 71879-136 | YUTIQ | fluocinolone acetonide | EyePoint Pharmaceuticals, Inc | NDA | Current |